Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | C-X-C chemokine receptor type 4 | ||
Ligand | BDBM50244271 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_492183 (CHEMBL951559) | ||
IC50 | 3000±n/a nM | ||
Citation | Ueda, S; Kato, M; Inuki, S; Ohno, H; Evans, B; Wang, ZX; Peiper, SC; Izumi, K; Kodama, E; Matsuoka, M; Nagasawa, H; Oishi, S; Fujii, N Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach. Bioorg Med Chem Lett18:4124-9 (2008) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
C-X-C chemokine receptor type 4 | |||
Name: | C-X-C chemokine receptor type 4 | ||
Synonyms: | C-X-C chemokine receptor type 4 | C-X-C chemokine receptor type 4 (CXCR4) | CD_antigen=CD184 | CXC-R4 | CXCR-4 | CXCR4 | CXCR4_HUMAN | FB22 | Fusin | HM89 | LCR1 | LESTR | Leukocyte-derived seven transmembrane domain receptor | NPYRL | SDF-1 receptor | Stromal cell-derived factor 1 receptor | ||
Type: | Enzyme | ||
Mol. Mass.: | 39754.61 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P61073 | ||
Residue: | 352 | ||
Sequence: |
| ||
BDBM50244271 | |||
n/a | |||
Name | BDBM50244271 | ||
Synonyms: | 5-(2-Guanidino-acetylamino)-1-(3-guanidino-propyl)-1H-indole-2-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-amide | CHEMBL472323 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H32N10O2 | ||
Mol. Mass. | 516.5981 | ||
SMILES | NC(N)=NCCCn1c(cc2cc(NC(=O)CN=C(N)N)ccc12)C(=O)NCCc1c[nH]c2ccccc12 |(26.4,-21.74,;27.43,-20.6,;28.94,-20.92,;26.95,-19.13,;27.98,-17.99,;27.51,-16.52,;28.54,-15.38,;28.06,-13.92,;28.97,-12.66,;28.06,-11.41,;26.59,-11.89,;25.25,-11.12,;23.92,-11.89,;22.59,-11.12,;21.25,-11.89,;21.25,-13.43,;19.92,-11.12,;18.59,-11.89,;17.25,-11.12,;15.92,-11.89,;17.25,-9.58,;23.92,-13.44,;25.25,-14.21,;26.59,-13.44,;30.51,-12.66,;31.28,-13.99,;31.28,-11.33,;32.82,-11.33,;33.59,-9.99,;35.13,-9.99,;36.04,-8.74,;37.51,-9.22,;37.51,-10.76,;38.64,-11.78,;38.33,-13.27,;36.86,-13.75,;35.73,-12.72,;36.05,-11.23,)| | ||
Structure |